10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 2 filers reported holding 10X GENOMICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,565,250 | -28.8% | 183,400 | -3.6% | 0.01% | -14.3% |
Q2 2023 | $10,626,352 | +15.4% | 190,300 | +15.3% | 0.01% | +16.7% |
Q1 2023 | $9,210,929 | +37.7% | 165,100 | -10.1% | 0.01% | +20.0% |
Q4 2022 | $6,690,384 | +17.2% | 183,600 | -8.4% | 0.01% | +25.0% |
Q3 2022 | $5,710,000 | -36.3% | 200,500 | +1.3% | 0.00% | -33.3% |
Q2 2022 | $8,960,000 | -65.1% | 198,000 | -41.3% | 0.01% | -57.1% |
Q1 2022 | $25,653,000 | -41.1% | 337,224 | +15.2% | 0.01% | -46.2% |
Q4 2021 | $43,589,000 | +2.1% | 292,624 | -0.2% | 0.03% | -3.7% |
Q3 2021 | $42,688,000 | -26.9% | 293,224 | -1.7% | 0.03% | -25.0% |
Q2 2021 | $58,418,000 | +30.9% | 298,324 | +21.0% | 0.04% | +20.0% |
Q1 2021 | $44,635,000 | +35.9% | 246,600 | +6.3% | 0.03% | +30.4% |
Q4 2020 | $32,837,000 | – | 231,900 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 1,753,528 | $133,391,000 | 100.00% |
Foresite Capital Management I, LLC | 750,000 | $57,053,000 | 99.71% |
12 West Capital Management LP | 2,518,500 | $191,582,000 | 11.65% |
Meritech Capital Associates V L.L.C. | 1,336,253 | $101,649,000 | 9.59% |
Blue Water Life Science Advisors, LP | 211,917 | $16,121,000 | 7.65% |
Decheng Capital Management III (Cayman), LLC | 303,984 | $23,124,000 | 7.09% |
FINANCIAL CONSULATE, INC | 154,942 | $11,786,000 | 4.53% |
Evolutionary Tree Capital Management, LLC | 54,128 | $4,118,000 | 2.86% |
HARVARD MANAGEMENT CO INC | 186,143 | $14,160,000 | 1.43% |
Brown Capital Management | 1,663,469 | $126,540,000 | 1.26% |